Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8457543rdf:typepubmed:Citationlld:pubmed
pubmed-article:8457543lifeskim:mentionsumls-concept:C0040549lld:lifeskim
pubmed-article:8457543lifeskim:mentionsumls-concept:C0205217lld:lifeskim
pubmed-article:8457543lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:8457543lifeskim:mentionsumls-concept:C0023688lld:lifeskim
pubmed-article:8457543lifeskim:mentionsumls-concept:C0038477lld:lifeskim
pubmed-article:8457543lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:8457543lifeskim:mentionsumls-concept:C0036451lld:lifeskim
pubmed-article:8457543lifeskim:mentionsumls-concept:C1510827lld:lifeskim
pubmed-article:8457543lifeskim:mentionsumls-concept:C0439799lld:lifeskim
pubmed-article:8457543lifeskim:mentionsumls-concept:C0243071lld:lifeskim
pubmed-article:8457543lifeskim:mentionsumls-concept:C1548700lld:lifeskim
pubmed-article:8457543lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:8457543pubmed:issue11lld:pubmed
pubmed-article:8457543pubmed:dateCreated1993-4-23lld:pubmed
pubmed-article:8457543pubmed:abstractTextThe venom of the scorpion Androctonus mauretanicus mauretanicus contains a toxin, P05, which is structurally and functionally similar to scorpion leiurotoxin I (87% sequence identity), a blocker of the apamin-sensitive Ca(2+)-activated K+ channels. It is a 31-residue polypeptide cross-linked by three disulfide bridges. A C-terminal carboxyl-amidated analog of P05 (sP05-NH2) was chemically synthesized by the solid-phase technique and fully characterized. Toxicity assays in vivo established that sP05-NH2, like native P05, is a potent and lethal neurotoxic agent in mice (LD50 of 20 ng per mouse). Pharmacological assays in vitro however showed that, unlike P05 which has a binding affinity of 2 x 10(-11) M, sP05-NH2 apparently binds irreversibly to the apamin receptor. Iodination at the C-terminal His gave diiodo-sP05-NH2, which had a binding affinity similar to that of native P05. The disulfide bridge pairings were chemically determined for sP05-NH2 and thereby deduced for P05 and leiurotoxin I: linkages were between Cys3 and Cys21, Cys8 and Cys26, and Cys12 and Cys28. Molecular dynamics refinement of P05 also using data from leiurotoxin I suggests that P05 is mainly composed of a double-stranded, antiparallel beta-sheet (from Leu18 to Val29) linked to an alpha-helix (from Arg6 to Gly16) by two disulfides (Cys8-Cys26 and Cys12-Cys28) and to an extended fragment (from Thr1 to Leu5) by the third disulfide (Cys3-Cys21). In agreement with the model, circular dichroism analysis of sP05-NH2 showed that the toxin structure is highly rigid.(ABSTRACT TRUNCATED AT 250 WORDS)lld:pubmed
pubmed-article:8457543pubmed:languageenglld:pubmed
pubmed-article:8457543pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8457543pubmed:citationSubsetIMlld:pubmed
pubmed-article:8457543pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8457543pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8457543pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8457543pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8457543pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8457543pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8457543pubmed:statusMEDLINElld:pubmed
pubmed-article:8457543pubmed:monthMarlld:pubmed
pubmed-article:8457543pubmed:issn0006-2960lld:pubmed
pubmed-article:8457543pubmed:authorpubmed-author:RochatHHlld:pubmed
pubmed-article:8457543pubmed:authorpubmed-author:Van...lld:pubmed
pubmed-article:8457543pubmed:authorpubmed-author:Martin-Eaucla...lld:pubmed
pubmed-article:8457543pubmed:authorpubmed-author:DarbonHHlld:pubmed
pubmed-article:8457543pubmed:authorpubmed-author:MabroukKKlld:pubmed
pubmed-article:8457543pubmed:authorpubmed-author:BenslimaneAAlld:pubmed
pubmed-article:8457543pubmed:authorpubmed-author:SabatierJ MJMlld:pubmed
pubmed-article:8457543pubmed:authorpubmed-author:ZerroukHHlld:pubmed
pubmed-article:8457543pubmed:issnTypePrintlld:pubmed
pubmed-article:8457543pubmed:day23lld:pubmed
pubmed-article:8457543pubmed:volume32lld:pubmed
pubmed-article:8457543pubmed:ownerNLMlld:pubmed
pubmed-article:8457543pubmed:authorsCompleteYlld:pubmed
pubmed-article:8457543pubmed:pagination2763-70lld:pubmed
pubmed-article:8457543pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8457543pubmed:meshHeadingpubmed-meshheading:8457543-...lld:pubmed
pubmed-article:8457543pubmed:meshHeadingpubmed-meshheading:8457543-...lld:pubmed
pubmed-article:8457543pubmed:meshHeadingpubmed-meshheading:8457543-...lld:pubmed
pubmed-article:8457543pubmed:meshHeadingpubmed-meshheading:8457543-...lld:pubmed
pubmed-article:8457543pubmed:meshHeadingpubmed-meshheading:8457543-...lld:pubmed
pubmed-article:8457543pubmed:meshHeadingpubmed-meshheading:8457543-...lld:pubmed
pubmed-article:8457543pubmed:meshHeadingpubmed-meshheading:8457543-...lld:pubmed
pubmed-article:8457543pubmed:meshHeadingpubmed-meshheading:8457543-...lld:pubmed
pubmed-article:8457543pubmed:meshHeadingpubmed-meshheading:8457543-...lld:pubmed
pubmed-article:8457543pubmed:meshHeadingpubmed-meshheading:8457543-...lld:pubmed
pubmed-article:8457543pubmed:meshHeadingpubmed-meshheading:8457543-...lld:pubmed
pubmed-article:8457543pubmed:meshHeadingpubmed-meshheading:8457543-...lld:pubmed
pubmed-article:8457543pubmed:meshHeadingpubmed-meshheading:8457543-...lld:pubmed
pubmed-article:8457543pubmed:meshHeadingpubmed-meshheading:8457543-...lld:pubmed
pubmed-article:8457543pubmed:meshHeadingpubmed-meshheading:8457543-...lld:pubmed
pubmed-article:8457543pubmed:meshHeadingpubmed-meshheading:8457543-...lld:pubmed
pubmed-article:8457543pubmed:meshHeadingpubmed-meshheading:8457543-...lld:pubmed
pubmed-article:8457543pubmed:meshHeadingpubmed-meshheading:8457543-...lld:pubmed
pubmed-article:8457543pubmed:meshHeadingpubmed-meshheading:8457543-...lld:pubmed
pubmed-article:8457543pubmed:meshHeadingpubmed-meshheading:8457543-...lld:pubmed
pubmed-article:8457543pubmed:year1993lld:pubmed
pubmed-article:8457543pubmed:articleTitleP05, a new leiurotoxin I-like scorpion toxin: synthesis and structure-activity relationships of the alpha-amidated analog, a ligand of Ca(2+)-activated K+ channels with increased affinity.lld:pubmed
pubmed-article:8457543pubmed:affiliationLaboratoire de Biochimie, CNRS URA 1455, Faculté de Médecine Nord, Marseille, France.lld:pubmed
pubmed-article:8457543pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8457543pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8457543lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8457543lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8457543lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8457543lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8457543lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8457543lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8457543lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8457543lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8457543lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8457543lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8457543lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8457543lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8457543lld:pubmed